We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Stryker Worldwide

evelops medical products and technologies, including Implants (joint replacement), Trauma, Craniomaxillofacial, Spina... read more Featured Products: More products

Download Mobile App




Ultrasonic Technology Augments Soft Tissue Fixation

By HospiMedica International staff writers
Posted on 10 Aug 2016
Print article
Image: The SonicAnchor bioresorbable implant (Photo courtesy of Stryker).
Image: The SonicAnchor bioresorbable implant (Photo courtesy of Stryker).
A new bioresorbable implant utilizes ultrasonic energy to liquefy and flow into cancellous bone to provide stable soft tissue to bone fixation.

The Stryker (Kalamazoo, MI, USA) SonicAnchor is a bioresorbable implant made of poly-L-DL-lactic acid (PLDLLA), which is placed into a hole drilled into the cancellous bone. Once high frequency, low amplitude ultrasonic energy is applied to liquefy the tip of the implant, PLDLLA flows into the bone cavities. Following cessation of the ultrasound pulse, the material re-solidifies and hardens, providing stable three-dimensional (3D) anchoring within five seconds.

The SonicAnchor is intended for suture or tissue fixation in foot, ankle, knee, hand, wrist, elbow, and shoulder open procedures. Examples include Achilles tendon repair, lateral and medial stabilization, hallux valgus reconstruction, midfoot reconstruction, metatarsal ligament repair, and digital tendon transfer. Even with its small, 2.5 mm diameter footprint, the SonicAnchor demonstrates significant enhancement in dynamic load stability, lower risk of breakage during insertion, and high pull out strength and reliability.

“Stryker is helping drive innovation in the industry with SonicAnchor and its unique fixation technology,” said orthopedic surgeon Adam Schiff, MD, of Loyola University Medical Center (Maywood, IL, USA), who has performed several procedures using the product. “Every time I place one, I am truly impressed by the strength and performance of this small implant.”

“SonicAnchor is transforming the soft tissue experience, and we are excited Stryker is leading the way in providing this innovative solution to orthopedic surgeons,” said Tom Popeck, vice president and general manager of Stryker's Foot and Ankle business unit. “SonicFusion technology is unlike any other on the market.”

Polylactide is biodegradable thermoplastic aliphatic polyester derived from renewable resources, such as cornstarch, tapioca roots, or sugarcane. It can be processed by extrusion, 3D printing, injection molding, film and sheet casting, and spinning, providing access to a wide range of products. Since it degrades into innocuous lactic acid, it is often used in surgery in the form of anchors, screws, plates, pins, rods, and as a mesh. Depending on the exact type used, it breaks down inside the body within 6 months to 2 years.

Related Links:
Stryker


New
Gold Member
X-Ray QA Meter
T3 AD Pro
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Mini C-arm Imaging System
Fluoroscan InSight FD
New
Medical-Grade POC Terminal
POC-821

Print article

Channels

Critical Care

view channel
Image: This handheld scanner is moved over breast tissue to monitor how well breast cancer tumors respond to chemotherapy or radiation treatment (Photo courtesy of Boston University)

Novel Medical Device Inventions Use Light to Monitor Blood Pressure and Track Cancer Treatment Progress

Traditional blood pressure devices often leave room for human error. To address this, scientists at Boston University (Boston, MA, USA) have developed a new blood pressure monitoring device based on speckle... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.